Literature DB >> 25623486

General hospital-treated self-poisoning in England and Australia: comparison of presentation rates, clinical characteristics and aftercare based on sentinel unit data.

Sarah Hiles1, Helen Bergen2, Keith Hawton2, Terry Lewin1, Ian Whyte3, Gregory Carter4.   

Abstract

OBJECTIVE: Hospital-treated deliberate self-poisoning (DSP) is common and the existing national monitoring systems are often deficient. Clinical Practice Guidelines (UK and Australia) recommend universal psychosocial assessment within the general hospital as standard care. We compared presentation rates, patient characteristics, psychosocial assessment and aftercare in UK and Australia.
METHODS: We used a cross sectional design, for a ten year study of all DSP presentations identified through sentinel units in Oxford, UK (n=3042) and Newcastle, Australia (n=3492).
RESULTS: Oxford had higher presentation rates for females (standardised rate ratio 2.4: CI 99% 1.9, 3.2) and males (SRR 2.5: CI 99% 1.7, 3.5). Female to male ratio was 1.6:1, 70% presented after-hours, 95% were admitted to a general hospital and co-ingestion of alcohol occurred in a substantial minority (Oxford 24%, Newcastle 32%). Paracetamol, minor tranquilisers and antidepressants were the commonest drug groups ingested, although the overall pattern differed. Psychosocial assessment rates were high (Oxford 80%, Newcastle 93%). Discharge referral for psychiatric inpatient admission (Oxford 8%, Newcastle 28%), discharge to home (Oxford 80%, Newcastle 70%) and absconding (Oxford 11%, Newcastle 2%) differed between the two units.
CONCLUSIONS: Oxford has higher age-standardised rates of DSP than Newcastle, although many other characteristics of patients are similar. Services can provide a high level of assessment as recommended in clinical guidelines. There is some variation in after-care. Sentinel service monitoring routine care of DSP patients can provide valuable comparisons between countries.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Deliberate self-poisoning; Epidemiology; Hospital services; Self-harm; Suicide attempt

Mesh:

Substances:

Year:  2015        PMID: 25623486     DOI: 10.1016/j.jpsychores.2015.01.006

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  6 in total

1.  Inpatient toxicology services improve resource utilization for intoxicated patients: a systematic review.

Authors:  Robert G Legg; Mark Little
Journal:  Br J Clin Pharmacol       Date:  2018-10-28       Impact factor: 4.335

2.  Detection of self-harm and suicidal ideation in emergency department triage notes.

Authors:  Vlada Rozova; Katrina Witt; Jo Robinson; Yan Li; Karin Verspoor
Journal:  J Am Med Inform Assoc       Date:  2022-01-29       Impact factor: 4.497

Review 3.  Pharmacological management of anticholinergic delirium - theory, evidence and practice.

Authors:  Andrew H Dawson; Nicholas A Buckley
Journal:  Br J Clin Pharmacol       Date:  2015-12-29       Impact factor: 4.335

4.  Trends in self-poisoning and psychotropic drug use in people aged 5-19 years: a population-based retrospective cohort study in Australia.

Authors:  Rose Cairns; Emily A Karanges; Anselm Wong; Jared A Brown; Jeff Robinson; Sallie-Anne Pearson; Andrew H Dawson; Nicholas A Buckley
Journal:  BMJ Open       Date:  2019-02-20       Impact factor: 2.692

5.  Effective psychological and psychosocial approaches to reduce repetition of self-harm: a systematic review, meta-analysis and meta-regression.

Authors:  Sarah E Hetrick; Jo Robinson; Matthew J Spittal; Greg Carter
Journal:  BMJ Open       Date:  2016-09-22       Impact factor: 2.692

6.  'Wasn't offered one, too poorly to ask for one' - Reasons why some patients do not receive a psychosocial assessment following self-harm: Qualitative patient and carer survey.

Authors:  Leah Quinlivan; Louise Gorman; Donna L Littlewood; Elizabeth Monaghan; Stephen J Barlow; Stephen Campbell; Roger T Webb; Nav Kapur
Journal:  Aust N Z J Psychiatry       Date:  2021-05-21       Impact factor: 5.744

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.